Dexketoprofen
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
Follow the administration instructions for the medication contained in this package leaflet or as indicated by your doctor or pharmacist.
Contents of the Package Leaflet
This medication is a pain reliever belonging to the group of medications known as non-steroidal anti-inflammatory drugs (NSAIDs).
Enandol is used in adults for the short-term symptomatic treatment of acute pain of mild to moderate intensity, such as muscle or joint pain (e.g., back pain, sprains, and acute trauma), menstrual pain, and toothache.
Do not take Enandol
Warnings and Precautions
Consult your doctor or pharmacist before starting to take Enandol:
Infections
Enandol may mask the signs of an infection, such as fever and pain. Consequently, this medication may delay the appropriate treatment of the infection, which may increase the risk of complications. This has been observed in bacterial pneumonia and bacterial skin infections related to chickenpox. If you take this medication while having an infection and the symptoms of the infection persist or worsen, consult a doctor without delay.
Avoid using this medication if you have chickenpox.
Children and Adolescents
This medication has not been studied in children or adolescents. Therefore, safety and efficacy have not been established, and it should not be used in children or adolescents.
Using Enandol with Other Medications
Tell your doctor or pharmacist if you are taking or have recently taken or may need to use any other medication, including those obtained without a prescription. There are some medications that should not be taken together, and others may require a dose change if taken together.
Always inform your doctor, dentist, or pharmacist if, in addition to this medication, you are taking any of the following medications:
Not Recommended Combinations:
Combinations that Require Caution:
Combinations to be Considered:
If you have any doubts about taking other medications with Enandol, consult your doctor or pharmacist.
Taking Enandol with Food, Drinks, and Alcohol
In general, it is recommended to take the medication with meals to reduce the possibility of causing stomach disorders (see also section 3, "Method of Administration").
The use of NSAIDs in combination with alcohol may worsen the adverse reactions caused by the active ingredient.
Pregnancy, Breastfeeding, and Fertility
Do not take this medication during the last three months of pregnancy or during breastfeeding. It may cause kidney and heart problems in your fetus. It may affect your and your baby's tendency to bleed and delay or prolong labor more than expected.
You should not take Enandol during the first six months of pregnancy unless it is clearly necessary and as indicated by your doctor. If you need treatment during this period or while trying to become pregnant, you should take the minimum dose for the shortest possible time.
From the 20th week of pregnancy, Enandol may cause kidney problems in your fetus if taken for more than a few days, which may lead to low levels of amniotic fluid surrounding the baby (oligohydramnios) or narrowing of a blood vessel (ductus arteriosus) in the baby's heart. If you need treatment for more than a few days, your doctor may recommend additional checks.
The use of this medication may impair fertility, so it is not recommended while trying to conceive or while investigating a fertility problem.
Driving and Using Machines
This medication may slightly affect your ability to drive and use machines, as it may cause drowsiness, dizziness, and blurred vision as side effects. If you notice these effects, do not use machines or drive until they disappear. Ask your doctor for advice.
Enandol Contains Sucrose
If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
It contains 2.418 g of sucrose per dose, which should be taken into account in patients with diabetes mellitus.
Follow the administration instructions for the medication contained in this package leaflet or as indicated by your doctor or pharmacist. In case of doubt, ask your doctor or pharmacist.
The necessary dose of the medication may vary depending on the type, intensity, and duration of the pain.
The lowest effective dose should be used for the shortest time necessary to relieve the symptoms. If you have an infection, consult a doctor without delay if the symptoms (such as fever and pain) persist or worsen (see section 2).
Adults Over 18 Years
Generally, the recommended dose is 1 sachet (25 mg of dexketoprofen) every 8 hours, not exceeding 3 sachets per day (75 mg).
Elderly Patients or Patients with Renal or Hepatic Impairment
If you are an elderly patient or have mild renal or hepatic impairment, it is recommended to start treatment with a maximum of 2 sachets per day (50 mg of dexketoprofen).
In elderly patients, this initial dose may be increased later according to the general recommended dose (75 mg of dexketoprofen) if dexketoprofen has been well tolerated.
You should not use dexketoprofen if you have moderate or severe renal impairment or severe hepatic impairment. Consult your doctor or pharmacist if you are unsure.
Use in Children and Adolescents
This medication should not be used in children and adolescents (under 18 years).
Method of Administration
Dissolve the entire contents of a sachet in a glass of water; stir to help dissolve. The resulting solution should be taken immediately after reconstitution.
The medication can be taken with or without food. Taking the medication with food helps reduce the risk of stomach disorders; however, if your pain is more intense and you need faster relief, take the sachet on an empty stomach (at least 15 minutes before any meal or food intake) because it will be absorbed more easily (see section 2, "Taking Enandol with Food, Drinks, and Alcohol").
Duration of Treatment
Treatment should not exceed 4 days. If the pain persists after this period or worsens, or if other symptoms appear, you should stop treatment and consult your doctor or pharmacist.
If You Take More Enandol Than You Should
Consult your doctor, pharmacist, or call the Toxicology Information Service, phone 91.562.04.20, indicating the medication and the amount taken. It is recommended to bring the packaging and package leaflet of the medication to the healthcare professional.
If You Forget to Take Enandol
Do not take a double dose to make up for forgotten doses. Take the next dose when scheduled (according to section 3, "How to Take Enandol").
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
Possible adverse effects are detailed below according to frequency. Since the list is based in part on adverse effects observed with oral use of tablets, and the oral solution granule is absorbed faster than tablets, it is possible that the actual frequency of adverse effects (gastrointestinal) may be higher in the oral solution granule.
Frequent Adverse Effects:may affect up to 1 in 10 people
Nausea and/or vomiting, mainly pain in the upper abdominal quadrant, diarrhea, digestive disorders (dyspepsia).
Uncommon Adverse Effects:may affect up to 1 in 100 people
Rotatory sensation (vertigo), dizziness, somnolence, sleep disorders, nervousness, headache, palpitations, hot flashes, inflammation of the stomach wall (gastritis), constipation, dry mouth, flatulence, skin rash, fatigue, pain, febrile sensation, and chills, general malaise.
Rare Adverse Effects:may affect up to 1 in 1,000 people
Peptic ulcer, peptic ulcer perforation or bleeding (which may manifest with vomiting blood or black stools), fainting, high blood pressure, slow breathing, fluid retention, and peripheral edema (e.g., swelling of ankles), laryngeal edema, loss of appetite (anorexia), abnormal sensation, pruritic rash, acne, increased sweating, lower back pain, frequent urination, menstrual disorders, prostate disorders, abnormal liver function tests (blood tests), liver cell damage (hepatitis), acute kidney failure.
Very Rare Adverse Effects:may affect up to 1 in 10,000 people
Anaphylactic reaction (hypersensitivity reaction that can also lead to collapse), ulcers on the skin, mouth, eyes, and genital areas (Stevens-Johnson syndrome and Lyell syndrome), swelling of the face or swelling of the lips and throat (angioedema), difficulty breathing due to narrowing of the airways (bronchospasm), shortness of breath, tachycardia, low blood pressure, pancreatitis, blurred vision, ringing in the ears (tinnitus), sensitive skin, sensitivity to light, itching, kidney problems. Decrease in the number of white blood cells (neutropenia), decrease in the number of platelets (thrombocytopenia).
Inform your doctor immediately if you notice any adverse effect of a gastrointestinal type at the start of treatment (e.g., stomach pain or burning or bleeding), if you have previously suffered from any of these adverse effects due to prolonged treatment with non-steroidal anti-inflammatory drugs, and especially if you are elderly.
Stop taking this medicine immediately if you notice the appearance of a skin rash or any lesion inside the mouth or on the genitals, or any other sign of allergy.
During treatment with non-steroidal anti-inflammatory drugs, cases of fluid retention and swelling (especially in ankles and legs), increased blood pressure, and heart failure have been reported.
Medicines like Enandol may be associated with a small increased risk of suffering a heart attack ("myocardial infarction") or a stroke ("stroke").
In patients with immune system disorders that affect connective tissue (systemic lupus erythematosus or mixed connective tissue disease), non-steroidal anti-inflammatory drugs can rarely cause fever, headache, and neck stiffness.
The most commonly observed adverse effects are of a gastrointestinal type. Peptic ulcers, perforation, or gastrointestinal bleeding, sometimes fatal, especially in elderly patients, may occur.
After administration, nausea, vomiting, diarrhea, flatulence, constipation, dyspepsia, abdominal pain, melena, hematemesis, ulcerative stomatitis, worsening of colitis, and Crohn's disease have been reported. Less frequently, inflammation of the stomach wall (gastritis) has been observed.
As with other non-steroidal anti-inflammatory drugs, hematological reactions (purpura, aplastic and hemolytic anemia, and more rarely agranulocytosis and bone marrow hypoplasia) may appear.
Adverse Effect Reporting
If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date that appears on the packaging and on the envelope after CAD. The expiration date is the last day of the month indicated.
No special storage conditions are required.
Medicines should not be thrown down the drain or into the trash. Deposit the packaging and medicines you no longer need in the SIGRE Point of the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.
Composition of Enandol
Appearance of Enandol and Package Contents
Lemon-yellow granule.
The oral solution granule is presented in single-dose heat-sealed envelopes of starch-aluminum-polyethylene.
Available in packages of 10 envelopes.
Marketing Authorization Holder
MENARINI CONSUMER HEALTHCARE, S.A.U.
Guifré, 724 - 08918 Badalona (Barcelona) Spain
Manufacturer
LABORATORIOS MENARINI, S.A.
Alfons XII, 587 – 08918 Badalona (Barcelona) Spain
Date of the Last Revision of this Prospectus:April 2023
Other Sources of Information
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es//.